Avecho Entitlement Offer Investor Webinar | 4 April 2023
Avecho Biotechnology hosted an investor webinar and Q&A with CEO, Dr Paul Gavin, to discuss the Company’s investment proposition and rationale for its Entitlement Offer to provide funds for conducting a Phase III clinical trial in respect of the Company’s proprietary TPM enhanced CBD soft-gel capsule.
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Avecho Biotechnology. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Avecho Biotechnology a question about this update.